Phosphatidylethanolamine facilitates mitochondrial pyruvate entry to regulate metabolic flexibility

Carbohydrates and lipids provide the majority of substrates to fuel mitochondrial oxidative phosphorylation (OXPHOS). Metabolic inflexibility, defined as an impaired ability to switch between these fuels, is implicated in a number of metabolic diseases. Here we explore the mechanism by which physical inactivity promotes metabolic inflexibility in skeletal muscle. We developed a mouse model of sedentariness by small mouse cage (SMC) that, unlike other classic models of disuse in mice, faithfully recapitulates metabolic responses that occur in humans. Bioenergetic phenotyping of mitochondria displayed metabolic inflexibility induced by physical inactivity, demonstrated by a reduction in pyruvate-stimulated respiration (JO2) in absence of a change in palmitate-stimulated JO2. Pyruvate resistance in these mitochondria was likely driven by a decrease in phosphatidylethanolamine (PE) abundance in the mitochondrial membrane. Reduction in mitochondrial PE by deletion of phosphatidylserine decarboxylase (PSD) was sufficient to induce metabolic inflexibility measured at the whole-body level, as well as at the level of skeletal muscle mitochondria. Low mitochondrial PE was sufficient to increase glucose flux towards lactate. We further implicate that resistance to pyruvate metabolism is due to attenuated mitochondrial entry via mitochondrial pyruvate carrier (MPC). These findings suggest a novel mechanism by which mitochondrial PE directly regulates MPC activity to modulate metabolic flexibility.

[1]  K. Parnell,et al.  The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. , 2020, Cell metabolism.

[2]  Hiroaki Eshima,et al.  Neutralizing mitochondrial ROS does not rescue muscle atrophy induced by hindlimb unloading in female mice. , 2020, Journal of applied physiology.

[3]  S. Powers,et al.  The COVID-19 pandemic and physical activity , 2020, Sports Medicine and Health Science.

[4]  Ryan M. O’Connell,et al.  Absence of MyD88 from Skeletal Muscle Protects Female Mice from Inactivity‐Induced Adiposity and Insulin Resistance , 2020, Obesity.

[5]  Sara M. Nowinski,et al.  Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. , 2019, Cell metabolism.

[6]  L. V. van Loon,et al.  Short‐term bed rest‐induced insulin resistance cannot be explained by increased mitochondrial H2O2 emission , 2019, The Journal of physiology.

[7]  Silvio Alessandro Di Gioia,et al.  The Liberfarb syndrome, a multisystem disorder affecting eye, ear, bone, and brain development, is caused by a founder pathogenic variant in the PISD gene , 2019, Genetics in Medicine.

[8]  P. Neufer,et al.  Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity , 2019, Science Advances.

[9]  Xianlin Han,et al.  Phosphatidylethanolamine made in the inner mitochondrial membrane is essential for yeast cytochrome bc1 complex function , 2019, Nature Communications.

[10]  G. Mortier,et al.  The homozygous variant c.797G>A/p.(Cys266Tyr) in PISD is associated with a Spondyloepimetaphyseal dysplasia with large epiphyses and disturbed mitochondrial function , 2018, Human mutation.

[11]  F. Bernier,et al.  PISD is a mitochondrial disease gene causing skeletal dysplasia, cataracts, and white matter changes , 2018, Life Science Alliance.

[12]  P. Neufer,et al.  Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome. , 2018, Journal of molecular and cellular cardiology.

[13]  Victoria S. Sprung,et al.  Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes , 2018, Diabetologia.

[14]  D. Bessesen,et al.  Sedentary behaviour is a key determinant of metabolic inflexibility , 2017, The Journal of physiology.

[15]  P. Neufer,et al.  Greater Oxidative Capacity in Primary Myotubes from Endurance-trained Women , 2017, Medicine and science in sports and exercise.

[16]  John A. Bowden,et al.  Expanding Lipidome Coverage Using LC-MS/MS Data-Dependent Acquisition with Automated Exclusion List Generation , 2017, Journal of The American Society for Mass Spectrometry.

[17]  W. Mechelen,et al.  The economic burden of physical inactivity: a global analysis of major non-communicable diseases , 2016, The Lancet.

[18]  P. Neufer,et al.  Looking Beyond Structure: Membrane Phospholipids of Skeletal Muscle Mitochondria , 2016, Trends in Endocrinology & Metabolism.

[19]  P. Neufer,et al.  Direct real-time quantification of mitochondrial oxidative phosphorylation efficiency in permeabilized skeletal muscle myofibers. , 2016, American journal of physiology. Cell physiology.

[20]  T. Endo,et al.  Phosphatidylserine transport by Ups2–Mdm35 in respiration-active mitochondria , 2016, The Journal of cell biology.

[21]  Luc J C van Loon,et al.  One Week of Bed Rest Leads to Substantial Muscle Atrophy and Induces Whole-Body Insulin Resistance in the Absence of Skeletal Muscle Lipid Accumulation , 2016, Diabetes.

[22]  B. Bergman,et al.  Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans. , 2016, Journal of applied physiology.

[23]  S. Klein,et al.  Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function , 2015, Diabetes.

[24]  A. Russell,et al.  The CDP-Ethanolamine Pathway Regulates Skeletal Muscle Diacylglycerol Content and Mitochondrial Biogenesis without Altering Insulin Sensitivity. , 2015, Cell metabolism.

[25]  Ajit S. Divakaruni,et al.  Measuring Mitochondrial Function in Permeabilized Cells Using the Seahorse XF Analyzer or a Clark‐Type Oxygen Electrode , 2014, Current protocols in toxicology.

[26]  J. Holloszy “Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance , 2013, Diabetes.

[27]  P. Even,et al.  Below Thermoneutrality, Changes in Activity Do Not Drive Changes in Total Daily Energy Expenditure between Groups of Mice , 2012, Cell metabolism.

[28]  S. Blair,et al.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.

[29]  Claire Redin,et al.  A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans , 2012, Science.

[30]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[31]  F. Booth,et al.  Lack of exercise is a major cause of chronic diseases. , 2012, Comprehensive Physiology.

[32]  A. Bergouignan,et al.  HIGHLIGHTED TOPIC Physiology and Pathophysiology of Physical Inactivity Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies , 2011 .

[33]  C. Hoppel,et al.  Mitochondrial Carnitine Palmitoyltransferase 1a (CPT1a) Is Part of an Outer Membrane Fatty Acid Transfer Complex* , 2011, The Journal of Biological Chemistry.

[34]  B. Pedersen,et al.  A 2-wk reduction of ambulatory activity attenuates peripheral insulin sensitivity. , 2010, Journal of applied physiology.

[35]  A. Vaag,et al.  Impact of 9 Days of Bed Rest on Hepatic and Peripheral Insulin Action, Insulin Secretion, and Whole-Body Lipolysis in Healthy Young Male Offspring of Patients With Type 2 Diabetes , 2009, Diabetes.

[36]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[37]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[38]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[39]  Frank W. Booth,et al.  Reduced physical activity and risk of chronic disease: the biology behind the consequences , 2008, European Journal of Applied Physiology.

[40]  J. Vance,et al.  Metabolism and functions of phosphatidylserine. , 2005, Progress in lipid research.

[41]  S. A. Thomson,et al.  Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. , 2005, Biochimica et biophysica acta.

[42]  Ruth K Globus,et al.  The hindlimb unloading rat model: literature overview, technique update and comparison with space flight data. , 2005, Advances in space biology and medicine.

[43]  M. Bergo,et al.  Defining the Importance of Phosphatidylserine Synthase 2 in Mice* , 2002, The Journal of Biological Chemistry.

[44]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[45]  S. Gordon,et al.  Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. , 2002, Journal of applied physiology.

[46]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[47]  J. Vance,et al.  A mitochondrial membrane protein is required for translocation of phosphatidylserine from mitochondria-associated membranes to mitochondria. , 1998, The Biochemical journal.

[48]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[49]  S. Lillioja,et al.  Skeletal muscle membrane lipid composition is related to adiposity and insulin action. , 1995, The Journal of clinical investigation.

[50]  Y. Itokawa,et al.  Mechanism of oxidative stress in skeletal muscle atrophied by immobilization. , 1993, The American journal of physiology.

[51]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[52]  F. Dela,et al.  Seven days of bed rest decrease insulin action on glucose uptake in leg and whole body. , 1991, Journal of applied physiology.

[53]  J. Vance Phospholipid synthesis in a membrane fraction associated with mitochondria. , 1990, The Journal of biological chemistry.

[54]  J. McGarry,et al.  A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. , 1977, The Journal of clinical investigation.

[55]  E. P. Kennedy,et al.  The function of cytidine coenzymes in the biosynthesis of phospholipides. , 1956, The Journal of biological chemistry.

[56]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.